BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

789 related articles for article (PubMed ID: 28661031)

  • 1. Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.
    Safarzadeh E; Orangi M; Mohammadi H; Babaie F; Baradaran B
    J Cell Physiol; 2018 Apr; 233(4):3024-3036. PubMed ID: 28661031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expansion and functions of myeloid-derived suppressor cells in the tumor microenvironment.
    Qu P; Wang LZ; Lin PC
    Cancer Lett; 2016 Sep; 380(1):253-6. PubMed ID: 26519756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
    Dysthe M; Parihar R
    Adv Exp Med Biol; 2020; 1224():117-140. PubMed ID: 32036608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Myeloid-Derived Suppressor Cells in Cancer Metastasis: Immunosuppression and Beyond.
    Pastaki Khoshbin A; Eskian M; Keshavarz-Fathi M; Rezaei N
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):89-102. PubMed ID: 30386868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
    Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
    Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
    Yin Z; Li C; Wang J; Xue L
    Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung resided monocytic myeloid-derived suppressor cells contribute to premetastatic niche formation by enhancing MMP-9 expression.
    Zhang J; Han X; Shi H; Gao Y; Qiao X; Li H; Wei M; Zeng X
    Mol Cell Probes; 2020 Apr; 50():101498. PubMed ID: 31891749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cells and tumor: Current knowledge and future perspectives.
    Safari E; Ghorghanlu S; Ahmadi-Khiavi H; Mehranfar S; Rezaei R; Motallebnezhad M
    J Cell Physiol; 2019 Jul; 234(7):9966-9981. PubMed ID: 30537008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Circulating Myeloid Suppressor Cells and Their Role in Tumour Immunology].
    Pilatova K; Budinská E; Bensciková B; Nenutil R; Šefr R; Fedorová L; Hanáková B; Brychtová V; Zdražilová Dubská L
    Klin Onkol; 2017; 30(Supplementum1):166-169. PubMed ID: 28471197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Brief: Myeloid-derived suppressor cells in cancer.
    Solito S; Pinton L; Mandruzzato S
    J Pathol; 2017 May; 242(1):7-9. PubMed ID: 28097660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of the Exosomes Derived From Myeloid-Derived Suppressor Cells in Tumor Immunity and Cancer Progression.
    Chen Z; Yuan R; Hu S; Yuan W; Sun Z
    Front Immunol; 2022; 13():817942. PubMed ID: 35154134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunobiology of myeloid-derived suppressor cells in cancer.
    Motallebnezhad M; Jadidi-Niaragh F; Qamsari ES; Bagheri S; Gharibi T; Yousefi M
    Tumour Biol; 2016 Feb; 37(2):1387-406. PubMed ID: 26611648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.
    Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G
    J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of myeloid-derived suppressor cells in metastasis.
    Cole K; Pravoverov K; Talmadge JE
    Cancer Metastasis Rev; 2021 Jun; 40(2):391-411. PubMed ID: 33411082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myeloid-Derived Suppressor Cells: Critical Cells Driving Immune Suppression in the Tumor Microenvironment.
    Parker KH; Beury DW; Ostrand-Rosenberg S
    Adv Cancer Res; 2015; 128():95-139. PubMed ID: 26216631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDSCs: The Key Players in the Formation of Pre-Metastatic Niche.
    Cui W; Wang Z; Lv J; Qin Y; Shi H
    Front Biosci (Landmark Ed); 2023 Mar; 28(3):58. PubMed ID: 37005751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche.
    Xia C; Bai W; Deng T; Li T; Zhang L; Lu Z; Zhang Z; Li M; He Q
    Acta Biomater; 2023 Mar; 158():708-724. PubMed ID: 36638937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LILRB4 promotes tumor metastasis by regulating MDSCs and inhibiting miR-1 family miRNAs.
    Su MT; Kumata S; Endo S; Okada Y; Takai T
    Oncoimmunology; 2022; 11(1):2060907. PubMed ID: 35402083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.